MedTrace Logo

SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom

NCT06504511 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-07-16

No results posted yet for this study

Summary

The aims of this prospective natural history study are to define the seizure, neuro-developmental, and behavioural characteristics of SCN1A-related epilepsies/Dravet syndrome in children and adults longitudinally over a period of three years. In addition, this study will compare missense and truncating genotypes in terms of i) rates of change of countable convulsive seizures per month and ii) neurodevelopmental outcome and trajectories.

Conditions

Sponsors & Collaborators

  • NHS Greater Glasgow and Clyde

    lead OTHER

Principal Investigators

  • Andreas Brunklaus, MD PhD · NHS Greater Glasgow & Clyde

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-20
Primary Completion
2026-06-01
Completion
2026-06-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06504511 on ClinicalTrials.gov